SCHEMBL23217219

SCHEMBL23217219

O=C(O)CC(=O)c1cc(Br)c2occc2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTNNB1 P35222 6/20 0.38
WNT3A P56704 6/20 0.38
XDH P47989 1/20 0.35
SLC22A12 Q96S37 1/20 0.35
IDO1 P14902 2/20 0.34
KLK7 P49862 1/20 0.34
TSHR P16473 1/20 0.33
CYP2C19 P33261 1/20 0.33
KDM4E B2RXH2 2/20 0.32
HTR1B P28222 1/20 0.32
GLA P06280 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
HPGD P15428 2/20 0.32
MEN1 O00255 1/20 0.32
CYP3A4 P08684 1/20 0.32
MAPT P10636 1/20 0.32
ALOX15 P16050 1/20 0.32
CES1 P23141 1/20 0.32
MAPK1 P28482 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26476323 0.84 PTPN1 (0.44) CTNNB1WNT3A
SCHEMBL5987785 0.82 TTR (0.47) CTNNB1WNT3AXDHSLC22A12TSHR
SCHEMBL23217552 0.80 NPC1 (0.34) CTNNB1WNT3AKDM4EMEN1MAPT
SCHEMBL30950146 0.78 MAPT (0.39) CTNNB1WNT3AXDHSLC22A12TSHR
SCHEMBL18585526 0.78 LCK (0.41) XDHSLC22A12TSHRMEN1KMT2A
SCHEMBL26095095 0.78 MAPT (0.39) CTNNB1WNT3AXDHSLC22A12TSHR
SCHEMBL5987396 0.77 NOTUM (0.44) XDHKDM4EL3MBTL1HPGDMEN1
SCHEMBL23217544 0.74 ALDH1A1 (0.46) TSHRMEN1CYP3A4MAPTKMT2A
SCHEMBL31026070 0.74 ALDH1A1 (0.46) TSHRMEN1CYP3A4MAPTKMT2A
SCHEMBL13736985 0.73 CTNNB1 (0.68) CTNNB1WNT3AIDO1HTR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021072156-A1 ORAL COMPLEMENT FACTOR D INHIBITORS BIOCRYST PHARMACEUTICALS, INC. (US) 2021-04-15 WO disclosed